CD11a与CD49d增强人类疫苗接种后抗原特异性T细胞的检测
在一项利什曼病候选疫苗I期试验中, naïve个体分别接种LEISH-F3重组蛋白联合SE、GLA-SE或MPL-SE佐剂,于第0、28、168天共3剂。结果显示CD11ahiCD49d+ CD4与CD8 T细胞频率自首剂后显著上升并持续24周,IFN-γ、TNF-α和IL-2产生细胞均位于该群内。作者认为该标志可追踪疫苗接种后抗原特异性T细胞应答。
要点
- CD11ahiCD49d+ CD4与CD8 T细胞频率自首剂后显著上升并持续至24周试验期间。
- LEISH-F3刺激后,IFN-γ、TNF-α和IL-2产生细胞均位于CD11ahiCD49d+群内。
- 作者认为CD11ahiCD49d+ T细胞频率变化可用于追踪抗原特异性CD4和CD8 T细胞应答。
核心结论
- 作者认为CD11ahiCD49d+ T细胞频率的变化可用于追踪T细胞靶向疫苗接种后的抗原特异性CD4和CD8 T细胞应答。
研究设计与样本
- I期疫苗试验,naïve个体随机接受LEISH-F3重组蛋白联合SE、GLA-SE或MPL-SE三种佐剂方案之一。
- 受试者于第0、28、168天共接种3剂疫苗,试验观察24周。
- 采用基于CD11a与CD49d表面表达的设门策略检测抗原特异性、产细胞因子的CD4和CD8 T细胞。
主要发现
- 自第一剂疫苗后开始,CD11ahiCD49d+ CD4与CD11ahiCD49d+ CD8 T细胞频率在整个24周试验期间随时间显著增加。
- LEISH-F3刺激后,所有产生IFN-γ、TNF-α和IL-2的细胞均位于CD11ahiCD49d+群体内。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Determining the efficacy of human vaccines that induce antigen-specific protective CD4 T cell responses against pathogens can be particularly challenging to evaluate. Surface expression of CD11a and CD49d has been shown to identify antigen-specific CD4 T cells against viral pathogens in mice. We hypothesized that CD11a and CD49d would also serve as markers of human antigen-specific T cells responding to vaccination. METHODS: A phase I vaccine trial enabled us to evaluate a novel gating strategy based on surface expression of CD11a and CD49d as a means of detecting antigen-specific, cytokine producing CD4 and CD8 T cells induced after vaccination of naïve individuals against leishmaniasis. Three study groups received LEISH-F3 recombinant protein combined with either squalene oil-in-water emulsion (SE) alone, SE with the synthetic TLR-4 ligand glucopyranosyl lipid adjuvant (GLA-SE), or SE with Salmonella minnesota-derived monophosphoryl lipid A (MPL-SE). Individuals were given 3 vaccine doses, on days 0, 28 and 168. RESULTS: Starting after the first vaccine dose, the frequency of both CD11ahiCD49d+ CD4 and CD11ahiCD49d+ CD8 T cells significantly increased over time throughout the 24-week trial. To confirm the role of CD11ahiCD49d+ expression in the identification of the antigen-specific T cells, cytokine production was measured following LEISH-F3 stimulation. All of the IFN-γ, TNF-α, and IL-2 producing cells were found within the CD11ahiCD49d+ population. CONCLUSIONS: Our results suggest that the change in the frequency of CD11ahiCD49d+ T cells can be used to track antigen-specific CD4 and CD8 T cell responses following T cell-targeted vaccination.
引用
- Christiaansen AF, Dixit UG, Coler RN, et al. CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination. Vaccine. 2017. PMID: 28662951. doi:10.1016/j.vaccine.2017.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。